Monte Carlo simulations identify suboptimal PK/PD target attainment with standard maribavir dosing.
Saved in:
| Title: | Monte Carlo simulations identify suboptimal PK/PD target attainment with standard maribavir dosing. |
|---|---|
| Authors: | Fromage Y; Inserm CIC 1435, CHU Dupuytren, Limoges, France.; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France., Sayadi H; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France.; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.; University Hospital Federation Survival Optimization in Organ Transplantation (FHU SUPORT), Limoges, France., Labriffe M; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France.; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.; University Hospital Federation Survival Optimization in Organ Transplantation (FHU SUPORT), Limoges, France., Codde C; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France.; Infectious and Tropical Diseases Unit, CHU Dupuytren, Limoges, France., Alain S; University Hospital Federation Survival Optimization in Organ Transplantation (FHU SUPORT), Limoges, France.; Microbiology Department, CHU Limoges, Limoges, France.; RESINFIT, UMR1092, Inserm, University of Limoges, CHU Limoges, Limoges, France.; National Reference Center for Herpesviruses, CHU Limoges, Limoges, France., Marquet P; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France.; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.; University Hospital Federation Survival Optimization in Organ Transplantation (FHU SUPORT), Limoges, France., Woillard JB; Inserm CIC 1435, CHU Dupuytren, Limoges, France.; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France.; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.; University Hospital Federation Survival Optimization in Organ Transplantation (FHU SUPORT), Limoges, France., Monchaud C; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France.; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.; University Hospital Federation Survival Optimization in Organ Transplantation (FHU SUPORT), Limoges, France. |
| Source: | The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2026 May 05; Vol. 81 (6). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42090285 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Monte Carlo simulations identify suboptimal PK/PD target attainment with standard maribavir dosing. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fromage+Y%22">Fromage Y</searchLink>; Inserm CIC 1435, CHU Dupuytren, Limoges, France.; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Sayadi+H%22">Sayadi H</searchLink>; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France.; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.; University Hospital Federation Survival Optimization in Organ Transplantation (FHU SUPORT), Limoges, France.<br /><searchLink fieldCode="AU" term="%22Labriffe+M%22">Labriffe M</searchLink>; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France.; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.; University Hospital Federation Survival Optimization in Organ Transplantation (FHU SUPORT), Limoges, France.<br /><searchLink fieldCode="AU" term="%22Codde+C%22">Codde C</searchLink>; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France.; Infectious and Tropical Diseases Unit, CHU Dupuytren, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Alain+S%22">Alain S</searchLink>; University Hospital Federation Survival Optimization in Organ Transplantation (FHU SUPORT), Limoges, France.; Microbiology Department, CHU Limoges, Limoges, France.; RESINFIT, UMR1092, Inserm, University of Limoges, CHU Limoges, Limoges, France.; National Reference Center for Herpesviruses, CHU Limoges, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Marquet+P%22">Marquet P</searchLink>; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France.; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.; University Hospital Federation Survival Optimization in Organ Transplantation (FHU SUPORT), Limoges, France.<br /><searchLink fieldCode="AU" term="%22Woillard+JB%22">Woillard JB</searchLink>; Inserm CIC 1435, CHU Dupuytren, Limoges, France.; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France.; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.; University Hospital Federation Survival Optimization in Organ Transplantation (FHU SUPORT), Limoges, France.<br /><searchLink fieldCode="AU" term="%22Monchaud+C%22">Monchaud C</searchLink>; Inserm UMR1248, Pharmacology & Transplantation, University of Limoges, Limoges, France.; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.; University Hospital Federation Survival Optimization in Organ Transplantation (FHU SUPORT), Limoges, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227513617%22">The Journal of antimicrobial chemotherapy</searchLink> [J Antimicrob Chemother] 2026 May 05; Vol. 81 (6). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7513617 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2091 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203057453%22">03057453 </searchLink><i>NLM ISO Abbreviation: </i>J Antimicrob Chemother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42090285 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/jac/dkag153 Languages: – Code: eng Text: English Titles: – TitleFull: Monte Carlo simulations identify suboptimal PK/PD target attainment with standard maribavir dosing. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fromage Y – PersonEntity: Name: NameFull: Sayadi H – PersonEntity: Name: NameFull: Labriffe M – PersonEntity: Name: NameFull: Codde C – PersonEntity: Name: NameFull: Alain S – PersonEntity: Name: NameFull: Marquet P – PersonEntity: Name: NameFull: Woillard JB – PersonEntity: Name: NameFull: Monchaud C IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 05 Text: 2026 May 05 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1460-2091 Numbering: – Type: volume Value: 81 – Type: issue Value: 6 Titles: – TitleFull: The Journal of antimicrobial chemotherapy Type: main |
| ResultId | 1 |